Stratec Se

Stratec Se Equity Ratio

The Equity Ratio of Stratec Se (SBS.DE) as of Nov 4, 2026 is 53.52 %. In the previous year, Equity Ratio was 54.49 % — a change of -1.78% (lower).

Equity Ratio

53.52 %

YoY

-1.78%

Last updated:

Equity Ratio of Stratec Se is 2025 53.52 % . Equity Ratio of Stratec Se was 2024 54.49 % . It decreases by -1.78% lower compared to the previous year.

The Stratec Se Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
55.29 EUR
Jan 1, 2019
53.11 EUR
Jan 1, 2020
51.99 EUR
Jan 1, 2021
55.83 EUR
Jan 1, 2022
56.65 EUR
Jan 1, 2023
50.01 EUR
Jan 1, 2024
54.49 EUR
Jan 1, 2025
53.52 EUR
The Stratec Se Equity Ratio history
YEAREquity RatioYoY
53.52 %-1.78%
54.49 %+8.97%
50.01 %-11.72%
56.65 %+1.46%
55.83 %+7.40%
51.99 %-2.11%
53.11 %-3.95%
55.29 %-7.60%
59.84 %+7.40%
55.71 %-32.03%
81.97 %+0.77%
81.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stratec Se Stock analysis

What does Stratec Se do? The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stratec Se stock

Equity Ratio of Stratec Se is 53.52 % in 2025.

Equity Ratio of Stratec Se changed from 54.49 % to 53.52 %, representing a -1.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Stratec Se since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Stratec Se with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Stratec Se

All Key Metrics — Stratec Se